You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 2, January 9, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy

P. A. Wingo, P. M. Layde, N. C. Lee, G. Rubin and H. W. Ory

We studied the association between estrogen replacement therapy (ERT) and the risk of breast cancer as part of the Cancer and Steroid Hormone Study. All subjects in the analysis were postmenopausal women enrolled from eight geographic areas. Women 25 to 54 years old with newly diagnosed breast cancer were identified through population-based tumor registries and diagnosed between Dec 1, 1980, and Dec 31, 1982. Controls were selected from the same eight geographic areas by the random digit dialing of residential telephone numbers. Analyses included 1369 cases and 1645 controls. Among women with bilateral oophorectomy, the relative risk of breast cancer for women who had ever used ERT was 1.3, compared with women who had never used ERT. Among women who had undergone hysterectomy but who still had at least one ovary, the relative risk was 1.1; among women who reported a natural menopause, the relative risk was 0.8. Overall, the risk of breast cancer did not appear to increase appreciably with increasing ERT duration or latency, even for durations and latencies of 20 years or longer.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hormone Replacement Therapy and Lung Cancer Risk: A Case-Control Analysis
Schabath et al.
Clin. Cancer Res. 2004;10:113-123.
ABSTRACT | FULL TEXT  

Breast Cancer and Hormonal Replacement Therapy
VASSILOPOULOU-SELLIN
Ann. N. Y. Acad. Sci. 2003;997:341-350.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy Regimens and Breast Cancer Risk
Weiss et al.
Obstet Gynecol 2002;100:1148-1158.
ABSTRACT | FULL TEXT  

Postmenopausal Estrogen and Progestin Use in Relation to Breast Cancer Risk
Newcomb et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:593-600.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy in Relation to Breast Cancer
Chen et al.
JAMA 2002;287:734-741.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Breast Cancer: A Qualitative Review
Bush et al.
Obstet Gynecol 2001;98:498-508.
ABSTRACT | FULL TEXT  

The menopause and its treatment in perspective
Al-Azzawi
Postgrad. Med. J. 2001;77:292-304.
FULL TEXT  

Breast cancer hypothesis: a single cause for the majority of cases
Wiseman
J. Epidemiol. Community Health 2000;54:851-858.
ABSTRACT | FULL TEXT  

Women need to be warned about dangers of hormone replacement therapy
Price et al.
BMJ 1997;314:376-376.
FULL TEXT  

Use of hormone replacement therapy
Mckinney
BMJ 1996;313:686-686.
FULL TEXT  

Postmenopausal Estrogens and Breast Cancer
Colditz
Reproductive Sciences 1996;3:50-56.
 

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
Colditz et al.
NEJM 1995;332:1589-1593.
ABSTRACT | FULL TEXT  

Hormonal Treatment of Postmenopausal Women
Belchetz
NEJM 1994;330:1062-1071.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.